Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desmopressin spray versus alarm therapy for primary nocturnal enuresis in children
IRCT20180428039453N1Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Sep 2017
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, open-label trial of desmopressin in nocturnal enuresis (NE) (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Rate of control and improvement of incontinence after use of alarm vs desmopressin and Medical response category. Started Sep 2017; status: completed.
02
Drugs
desmopressin
03
Conditions
nocturnal enuresis (NE)
Beyond the preview
Go deeper on IRCT20180428039453N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180428039453N1.